Advertisement

Topics

Higher incidence of acute kidney injuries forces Polyphor to pause late-stage studies of murepavadin; shares drop 48% https://www.firstwordpharma.com/node/1640162  $POLN

05:45 EDT 10 May 2019 | FirstWord Pharma

Higher incidence of acute kidney injuries forces Polyphor to pause late-stage studies of murepavadin; shares drop 48% https://www.firstwordpharma.com/node/1640162 

Original Article: Higher incidence of acute kidney injuries forces Polyphor to pause late-stage studies of murepavadin; shares drop 48% https://www.firstwordpharma.com/node/1640162  $POLN

NEXT ARTICLE

More From BioPortfolio on "Higher incidence of acute kidney injuries forces Polyphor to pause late-stage studies of murepavadin; shares drop 48% https://www.firstwordpharma.com/node/1640162  $POLN"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...